New York-Presbyterian NETT Consortium
纽约长老会 NTT 联盟
基本信息
- 批准号:7937816
- 负责人:
- 金额:$ 19.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAccident and Emergency departmentAcuteAcute Brain InjuriesAdmission activityAlteplaseAmbulancesArtsAwardBedsBlood VesselsBrainCaringCerebral hemisphere hemorrhageClinicalClinical ResearchClinical TrialsCoagulation ProcessCollaborationsCritical CareDataEmergency MedicineEmergency SituationEmergency treatmentEvaluationEvidence based interventionFactor VIIaFunctional Magnetic Resonance ImagingGoalsGrantHealthcare SystemsHeart ArrestHemostatic AgentsHospitalsHotlinesHourHypertensionInfusion proceduresIntensive CareIntensive Care UnitsInternetIschemic StrokeJointsLeadLeadershipLinkMedical StaffMedical centerMidazolamMorbidity - disease rateNational Institute of Neurological Disorders and StrokeNeedlesNeurologicNeurological emergenciesNeurologyNeuroprotective AgentsNeurosciencesNew YorkPatient CarePatientsPerformancePhysiciansPresbyterian ChurchPrincipal InvestigatorProceduresProcessProtocols documentationRecombinantsRecording of previous eventsRefractoryReperfusion TherapyResearchResearch InfrastructureResearch PersonnelResearch SupportRotationSiteSpecialistSpeedStatus EpilepticusStrokeSystemTestingTherapeuticThrombolytic TherapyTimeTraumaTreatment ProtocolsUnited StatesUnited States National Institutes of HealthX-Ray Computed Tomographyacute strokebaseeffective therapyimprovedintraventricular hemorrhagemortalitymultidisciplinarynatural hypothermianeonatal hypoxic-ischemic brain injurynervous system disorderneurosurgerypatient populationprogramspublic educationrecombinant FVIIaresponsestroke recoverytreatment trial
项目摘要
DESCRIPTION (provided by applicant): The two "hub" academic medical centers of the New York Presbyterian (NYP) Healthcare System - Columbia University Medical Center (CUMC) and Weill-Cornell Medical Center (WCMC) - have helped lead the way in developing promising new treatments for neurological emergencies. These include the application of therapeutic hypothermia after cardiac arrest, the Merci' clot retriever for acute ischemic stroke, midazolam infusion for refractory status epilepticus, and clinical trials evaluating neuroprotective agents for acute stroke, thrombolytic therapy for intraventricular hemorrhage, and ultra-early hemostatic therapy with recombinant activated factor VII for intracerebral hemorrhage. Columbia University Medical Center is one of seven NIH SPOTRIAS research centers; central to this effort is the multidisciplinary SPEED team, led by emergency medicine, which continuously evaluates acute stroke care at both of our hubs and has driven substantial reductions in door-to-needle times for IV t-PA. These cooperative efforts between emergency medicine and neurology are further supported by an established infrastructure that facilitates collaboration throughout the NYP Healthcare System, including a Stroke Center Clinical Council, Emergency Medicine System Forum, and one of the largest independent ambulance systems in the United States. The overall goal of the present application is to build on our existing expertise in clinical research, our history of collaboration between emergency medicine and the clinical neurosciences at our two hub hospitals, and our track record of well-coordinated efforts throughout the NYP Healthcare System, in order to develop a 10-hospital New York-Presbyterian NETT Consortium for conducting neuroemergency clinical trials. Collectively these 10 emergency departments treat an ethnically diverse patient population that exceeds one half million patients per year. We will pursue the following specific aims: (1) Establish a leadership group of four co-principal investigators representing emergency medicine and neurology from both of our hub hospitals, supported by two half-time NETT project coordinators; (2) Organize emergency medicine and neurology co-investigators at 8 additional NYP network hospitals, each supported by a part- time NETT coordinators; (3) Create a 24-hour physician coverage system to provide clinical and research support to our regional emergency departments; (4) Develop a new EMS-triggered pre-hospital warning system to reduce the time needed to trigger clinical trial procedures; (5) Formally link the NYP Stroke Center Clinical Council, NYP Emergency Medicine System Forum, and the SPOTRIAS Speed Team; and (6) Develop unified time-based performance standards for managing neuroemergency patients, and implement an internet-based surveillance system to provide continuous quality improvement (CQI) data for our sites.
描述(由申请人提供):纽约长老会 (NYP) 医疗保健系统的两个“中心”学术医疗中心 - 哥伦比亚大学医学中心 (CUMC) 和威尔康奈尔医学中心 (WCMC) - 帮助引领了发展有前景的神经紧急情况新疗法。其中包括心脏骤停后低温治疗的应用、急性缺血性中风的 Merci' 血栓回收器、难治性癫痫持续状态的咪达唑仑输注,以及评估急性中风神经保护剂、脑室内出血溶栓治疗和超早期止血治疗的临床试验重组激活因子 VII 治疗脑出血。哥伦比亚大学医学中心是 NIH SPOTRIAS 七个研究中心之一;这项工作的核心是由急诊医学领导的多学科 SPEED 团队,该团队不断评估我们两个中心的急性中风护理,并大幅缩短了 IV t-PA 的上门到注射时间。急诊医学和神经病学之间的这些合作努力得到了现有基础设施的进一步支持,该基础设施促进了整个纽约市医疗保健系统的合作,包括中风中心临床委员会、急诊医学系统论坛和美国最大的独立救护车系统之一。本申请的总体目标是建立在我们现有的临床研究专业知识、我们两家中心医院的急诊医学和临床神经科学之间的合作历史以及我们在整个纽约市医疗保健系统中协调良好的工作记录的基础上,旨在建立一个由 10 家医院组成的纽约长老会 NTT 联盟来进行神经急诊临床试验。这 10 个急诊科每年共同治疗超过 50 万名不同种族的患者。我们将追求以下具体目标: (1) 建立一个由四名联合首席研究员组成的领导小组,他们代表我们两家中心医院的急诊医学和神经病学,并由两名半职NETT项目协调员提供支持; (2) 在另外 8 家 NYP 网络医院组织急诊医学和神经病学联合研究者,每家医院均由一名兼职 NETT 协调员提供支持; (3)建立24小时医生覆盖体系,为区域急诊科室提供临床和科研支持; (4)开发新的EMS触发的院前预警系统,以减少触发临床试验程序所需的时间; (5) 正式链接 NYP 中风中心临床委员会、NYP 急诊医学系统论坛和 SPOTRIAS Speed 团队; (6) 制定统一的基于时间的神经急诊患者管理绩效标准,并实施基于互联网的监测系统,为我们的站点提供持续的质量改进 (CQI) 数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHAN A MAYER其他文献
STEPHAN A MAYER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHAN A MAYER', 18)}}的其他基金
相似海外基金
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
- 批准号:
10749448 - 财政年份:2023
- 资助金额:
$ 19.41万 - 项目类别:
Mixed methods examination of warning signs within 24 hours of suicide attempt in hospitalized adults
住院成人自杀未遂 24 小时内警告信号的混合方法检查
- 批准号:
10710712 - 财政年份:2023
- 资助金额:
$ 19.41万 - 项目类别:
Clinical effectiveness of a wearable hydration device
可穿戴水化装置的临床效果
- 批准号:
10773374 - 财政年份:2022
- 资助金额:
$ 19.41万 - 项目类别:
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications, and CBT4CBT: A randomized clinical trial in a diverse patient population
通过简短干预、药物和 CBT4CBT 促进住院后酒精治疗的参与:针对不同患者群体的随机临床试验
- 批准号:
10372677 - 财政年份:2021
- 资助金额:
$ 19.41万 - 项目类别:
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications, and CBT4CBT: A randomized clinical trial in a diverse patient population
通过简短干预、药物和 CBT4CBT 促进住院后酒精治疗的参与:针对不同患者群体的随机临床试验
- 批准号:
10491299 - 财政年份:2021
- 资助金额:
$ 19.41万 - 项目类别: